David C. Hastings - Jan 20, 2022 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Chief Financial Officer
Signature
David C Hastings
Stock symbol
ABUS
Transactions as of
Jan 20, 2022
Transactions value $
$800,850
Form type
4
Date filed
1/20/2022, 04:55 PM
Previous filing
Jan 19, 2022
Next filing
Jun 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Option (Right to Buy) Award $801K +285K $2.81 285K Jan 20, 2022 Common Shares 285K $2.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options will vest and become exercisable 1/48th each month over the four year period.